ADVM
Price
$2.32
Change
-$0.07 (-2.93%)
Updated
Aug 1 closing price
Capitalization
48.26M
AVIR
Price
$3.47
Change
-$0.17 (-4.67%)
Updated
Aug 1 closing price
Capitalization
296.96M
4 days until earnings call
Interact to see
Advertisement

ADVM vs AVIR

Header iconADVM vs AVIR Comparison
Open Charts ADVM vs AVIRBanner chart's image
Adverum Biotechnologies
Price$2.32
Change-$0.07 (-2.93%)
Volume$79.7K
Capitalization48.26M
Atea Pharmaceuticals
Price$3.47
Change-$0.17 (-4.67%)
Volume$313.75K
Capitalization296.96M
ADVM vs AVIR Comparison Chart in %
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. AVIR commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Hold and AVIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ADVM: $2.32 vs. AVIR: $3.47)
Brand notoriety: ADVM and AVIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 37% vs. AVIR: 80%
Market capitalization -- ADVM: $48.26M vs. AVIR: $296.96M
ADVM [@Biotechnology] is valued at $48.26M. AVIR’s [@Biotechnology] market capitalization is $296.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileAVIR’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • AVIR’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than ADVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 4 TA indicator(s) are bullish while AVIR’s TA Score has 5 bullish TA indicator(s).

  • ADVM’s TA Score: 4 bullish, 5 bearish.
  • AVIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а -14.07% price change this week, while AVIR (@Biotechnology) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

AVIR is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($297M) has a higher market cap than ADVM($48.3M). AVIR YTD gains are higher at: 3.582 vs. ADVM (-50.321). ADVM (-154.84M) and AVIR (-161.77M) have comparable annual earnings (EBITDA) . AVIR has more cash in the bank: 425M vs. ADVM (83.1M). AVIR has less debt than ADVM: AVIR (1.45M) vs ADVM (93.2M). ADVM has higher revenues than AVIR: ADVM (1M) vs AVIR (0).
ADVMAVIRADVM / AVIR
Capitalization48.3M297M16%
EBITDA-154.84M-161.77M96%
Gain YTD-50.3213.582-1,405%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash83.1M425M20%
Total Debt93.2M1.45M6,450%
FUNDAMENTALS RATINGS
ADVM vs AVIR: Fundamental Ratings
ADVM
AVIR
OUTLOOK RATING
1..100
8375
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
41
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
6547
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADVM's Valuation (37) in the Biotechnology industry is in the same range as AVIR (41). This means that ADVM’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as ADVM (100). This means that AVIR’s stock grew similarly to ADVM’s over the last 12 months.

AVIR's SMR Rating (94) in the Biotechnology industry is in the same range as ADVM (98). This means that AVIR’s stock grew similarly to ADVM’s over the last 12 months.

AVIR's Price Growth Rating (47) in the Biotechnology industry is in the same range as ADVM (65). This means that AVIR’s stock grew similarly to ADVM’s over the last 12 months.

AVIR's P/E Growth Rating (93) in the Biotechnology industry is in the same range as ADVM (100). This means that AVIR’s stock grew similarly to ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMAVIR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KISB36.250.25
+0.69%
Kish Bancorp, Inc.
NKRKF6.95N/A
N/A
Nokian Tyres Plc.
AWLCF1.81N/A
N/A
Awilco Drilling Ltd.
NPSNY60.27-1.44
-2.34%
Naspers Ltd.
IMPUF9.21-0.29
-3.05%
Impala Platinum Holdings Ltd.

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with XENE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-2.93%
XENE - ADVM
48%
Loosely correlated
-0.13%
OCUL - ADVM
47%
Loosely correlated
+2.94%
CCCC - ADVM
47%
Loosely correlated
+3.41%
RGNX - ADVM
46%
Loosely correlated
-3.76%
XNCR - ADVM
46%
Loosely correlated
-4.09%
More

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-4.67%
AXON - AVIR
46%
Loosely correlated
-1.72%
XENE - AVIR
45%
Loosely correlated
-0.13%
ZNTL - AVIR
43%
Loosely correlated
-2.90%
ADVM - AVIR
43%
Loosely correlated
-2.93%
IDYA - AVIR
42%
Loosely correlated
-0.33%
More